Skip to main content
OpenTrials
Completed

NCT Number: NCT00815503

Postoperative Analgesia With Local Infiltration After Periacetabular Osteotomy

Pain treatment after periacetabular osteotomy is traditionally based on systemic opioids wich have side effects. The purpose of this study is to evaluate the analgetic effect of wound infiltration with local anaesthesia after periacetabular osteotomy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Odense University Hospital

Odense, 5000, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Periacetabular osteotomy due to traditional dysplasia or retroverted acetabulum
  • Informed consent

Exclusion criteria

  • Intolerance of local anaesthesia
  • Habitual use of opioids

Treatment and study plan

Ropivacaine

Drug

Approved by the Danish Medicines Agency

Placebo

Drug

Saline

Primary outcomes

  1. Consumption of rescue analgetics

    Time frame: Assesment of opioid rescue analgetics every 24 hours for 14 days postoperatively

Secondary outcomes

  1. Pain

    Time frame: Assessment of pain four times every day for five days postoperatively

Sponsors and collaborators

Lead sponsor

Odense University Hospital

Other

Registry information

Official study title

Postoperative Analgesia With Local Infiltration After Periacetabular Osteotomy For The Treatment Of Dysplasia

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
Dec 30, 2008
Registry last updated
Mar 16, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.